Diagnostic and prognostic utility of tissue factor for severe sepsis and sepsis-induced acute lung injury

Journal of Translational Medicine

Volumn 13, Issue 1, 2015, Pages

  Xue, Mingming ^a   Sun, Zhan ^a   Shao, Mian ^a   Yin, Jun ^a   Deng, Zhi ^a   Zhang, Jin ^a   Xing, Lingyu ^a   Yang, Xiaoliang ^a   Chen, Bin ^a   Dong, Zhimin ^a   Han, Yi ^a   Sun, Si ^a   Wang, Yuxin ^a   Yao, Chenling ^a   Chu, Xun ^b   Tong, Chaoyang ^a   Song, Zhenju ^a  

^a FUDAN UNIVERSITY   (China)

^b CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

Author keywords

Acute respiratory distress syndrome; Severe sepsis; Tissue factor; Tissue factor pathway inhibitor

Indexed keywords

THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ACUTE LUNG INJURY; ADULT; AREA UNDER THE CURVE; ARTICLE; BACTERIUM DETECTION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEPSIS; SEPTIC SHOCK; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; SURVIVAL RATE; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; BLOOD; CASE CONTROL STUDY; COMPLICATION; METABOLISM; MIDDLE AGED; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

ACUTE LUNG INJURY; AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RESPIRATORY DISTRESS SYNDROME, ADULT; ROC CURVE; SEPSIS; SURVIVAL ANALYSIS; THROMBOPLASTIN; TREATMENT OUTCOME;

EID: 85019175672     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/s12967-015-0518-9     Document Type: Article

References (29)

1. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369:840-51.
2. Remick DG. Pathophysiology of sepsis. Am J Pathol. 2007;170:1435-44.
3. Anas AA, Wiersinga WJ, de Vos AF, van der Poll T. Recent insights into the pathogenesis of bacterial sepsis. Neth J Med. 2010;68:147-52.
4. Levi M, Ten CH. Disseminated intravascular coagulation. N Engl J Med. 1999;341:586-92.
5. Levi M. The coagulant response in sepsis and inflammation. Hamostaseologie. 2010;30:10-2.
6. Levi M, Van Der Poll T. Thrombomodulin in sepsis. Minerva Anestesiol. 2013;79:294-8.
7. Pawlinski R, Mackman N. Tissue factor, coagulation proteases, and protease-activated receptors in endotoxemia and sepsis. Crit Care Med. 2004;32:S293-7.
8. Edgington TS, Mackman N, Brand K, Ruf W. The structural biology of expression and function of tissue factor. Thromb Haemost. 1991;66:67-79.
9. Semeraro N, Ammollo CT, Semeraro F, Colucci M. Sepsis-associated disseminated intravascular coagulation and thromboembolic disease. Mediterr J Hematol Infect Dis. 2010;2:e2010024.
10. Pawlinski R, Mackman N. Cellular sources of tissue factor in endotoxemia and sepsis. Thromb Res. 2010;125 Suppl 1:S70-3.
11. Levi M. The coagulant response in sepsis. Clin Chest Med. 2008;29:627-42.
12. Gando S, Nanzaki S, Sasaki S, Kemmotsu O. Significant correlations between tissue factor and thrombin markers in trauma and septic patients with disseminated intravascular coagulation. Thromb Haemost. 1998;79:1111-5.
13. Broze GJ. The rediscovery and isolation of TFPI. J Thromb Haemost. 2003;1:1671-5.
14. Tang H, Ivanciu L, Popescu N, Peer G, Hack E, Lupu C, et al. Sepsis-induced coagulation in the baboon lung is associated with decreased tissue factor pathway inhibitor. Am J Pathol. 2007;171:1066-77.
15. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20:864-874.
16. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. The Consensus Committee. Intensive Care Med. 1994;20:225-32.
17. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307:2526-33.
18. Liang Y, Li X, Zhang X, Li Z, Wang L, Sun Y, et al. Elevated levels of plasma TNF-alpha are associated with microvascular endothelial dysfunction in patients with sepsis through activating the NF-kappaB and p38 mitogen-activated protein kinase in endothelial cells. Shock. 2014;41:275-81.
19. Gando S, Kameue T, Matsuda N, Hayakawa M, Morimoto Y, Ishitani T, et al. Imbalances between the levels of tissue factor and tissue factor pathway inhibitor in ARDS patients. Thromb Res. 2003;109:119-24.
20. Gando S, Nanzaki S, Morimoto Y, Kobayashi S, Kemmotsu O. Systemic activation of tissue-factor dependent coagulation pathway in evolving acute respiratory distress syndrome in patients with trauma and sepsis. J Trauma. 1999;47:719-23.
21. Kambas K, Markiewski MM, Pneumatikos IA, Rafail SS, Theodorou V, Konstantonis D, et al. C5a and TNF-alpha up-regulate the expression of tissue factor in intra-alveolar neutrophils of patients with the acute respiratory distress syndrome. J Immunol. 2008;180:7368-75.
22. Welty-Wolf KE, Carraway MS, Ortel TL, Piantadosi CA. Coagulation and inflammation in acute lung injury. Thromb Haemost. 2002;88:17-25.
23. Bastarache JA, Wang L, Geiser T, Wang Z, Albertine KH, Matthay MA, et al. The alveolar epithelium can initiate the extrinsic coagulation cascade through expression of tissue factor. Thorax. 2007;62:608-16.
24. Glas GJ, Van Der Sluijs KF, Schultz MJ, Hofstra JJ, Van Der Poll T, Levi M. Bronchoalveolar hemostasis in lung injury and acute respiratory distress syndrome. J Thromb Haemost. 2013;11:17-25.
25. Uusitalo-Jarvinen H, Kurokawa T, Mueller BM, Andrade-Gordon P, Friedlander M, Ruf W. Role of protease activated receptor 1 and 2 signaling in hypoxia-induced angiogenesis. Arterioscler Thromb Vasc Biol. 2007;27:1456-62.
26. He X, Han B, Mura M, Li L, Cypel M, Soderman A, et al. Anti-human tissue factor antibody ameliorated intestinal ischemia reperfusion-induced acute lung injury in human tissue factor knock-in mice. PLoS One. 2008;3:e1527.
27. He X, Han B, Bai X, Zhang Y, Cypel M, Mura M, et al. PTX3 as a potential biomarker of acute lung injury: supporting evidence from animal experimentation. Intensive Care Med. 2010;36:356-64.
28. Welty-Wolf KE, Carraway MS, Ortel TL, Ghio AJ, Idell S, Egan J, et al. Blockade of tissue factor-factor X binding attenuates sepsis-induced respiratory and renal failure. Am J Physiol Lung Cell Mol Physiol. 2006;290:L21-31.
29. Gando S, Kameue T, Morimoto Y, Matsuda N, Hayakawa M, Kemmotsu O. Tissue factor production not balanced by tissue factor pathway inhibitor in sepsis promotes poor prognosis. Crit Care Med. 2002;30:1729-34.